Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amylyx Pharmaceuticals

5.47
-0.0550-1.00%
Volume:589.20K
Turnover:3.21M
Market Cap:487.16M
PE:-1.81
High:5.54
Open:5.39
Low:5.33
Close:5.52
Loading ...

Amylyx Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
06 Jun

Amylyx Pharmaceuticals Announces FDA Fast Track Designation for AMX0114 in ALS Treatment, Phase 1 LUMINA Trial Underway

Reuters
·
03 Jun

Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for Amx0114 for the Treatment of Amyotrophic Lateral Sclerosis

THOMSON REUTERS
·
03 Jun

Amylyx Pharmaceuticals Inc - Phase 1 Lumina Trial Underway, Data Expected in 2025

THOMSON REUTERS
·
03 Jun

Amylyx Pharmaceuticals Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
30 May

Amylyx Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

Reuters
·
21 May

Amylyx Pharmaceuticals Is Maintained at Outperform by Mizuho

Dow Jones
·
14 May

Mizuho Adjusts Price Target on Amylyx Pharmaceuticals to $8 From $7, Maintains Outperform Rating

MT Newswires Live
·
14 May

Amylyx Pharmaceuticals Inc : Mizuho Raises Target Price to $8 From $7

THOMSON REUTERS
·
14 May

Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
09 May

Amylyx price target raised to $16 from $12 at H.C. Wainwright

TIPRANKS
·
09 May

Amylyx Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $16 From $12

THOMSON REUTERS
·
09 May

Amylyx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Amylyx Pharma Q1 EPS $(0.42) Beats $(0.49) Estimate

Benzinga
·
08 May

BRIEF-Amylyx Pharmaceuticals Q1 EPS USD -0.42 Vs. IBES Estimate USD -0.47

Reuters
·
08 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 May

Amylyx Pharmaceuticals Shares Rise After Upgrade From Leerink

MT Newswires Live
·
08 May

Leerink Upgrades Amylyx Pharmaceuticals to Outperform From Market Perform, Adjusts Price Target to $10 From $4

MT Newswires Live
·
07 May

Amylyx Pharmaceuticals Raised to Outperform From Market Perform by Leerink Partners

Dow Jones
·
07 May

Amylyx Pharmaceuticals Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
06 May